Clinical profile of severe asthmatics receiving biological treatment: see behind the scenes
- PMID: 32233981
- DOI: 10.1080/02770903.2020.1750629
Clinical profile of severe asthmatics receiving biological treatment: see behind the scenes
Abstract
The clinical phenotyping of severe asthma could improve treatment outcomes, quality of life, morbidity, and mortality of asthma patients. The growing availability of rich clinical data could provide opportunities to address a broad range of real-world questions regarding clinical phenotyping and effective therapeutic approaches of severe asthma. Accordingly, in this Letter to the Editor, we provide data relevant to constructing the clinical profile of a Greek severe asthma patient cohort who receive biological treatment.
Keywords: Asthma; Greece; mepolizumab; omalizumab; phenotype.
Comment on
-
Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study.J Asthma. 2021 Apr;58(4):459-470. doi: 10.1080/02770903.2019.1708095. Epub 2020 Jan 9. J Asthma. 2021. PMID: 31874051
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical